Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast sensitivity function in patients with beta-thalassemia major.

S P Gartaganis1, N Zoumbos, J X Koliopoulos

  • 1Department of Ophthalmology, University of Patras Medical School, Greece. ifigenia@hol.gr

Acta Ophthalmologica Scandinavica
|October 19, 2000
PubMed
Summary

Patients with beta-thalassemia major show significantly reduced contrast sensitivity function, even after regular treatment. Age is the primary predictor of this visual impairment, highlighting the need for monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia.

Bone marrow transplantation·2010
Same author

Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease.

Bone marrow transplantation·2010
Same author

Development of biodegradable controlled release scleral systems of triamcinolone acetonide.

Current eye research·2010
Same author

Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

Ocular surface bacterial colonisation in sedated intensive care unit patients.

Anaesthesia and intensive care·2010
Same author

Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia.

Leukemia·2010

Area of Science:

  • Ophthalmology
  • Hematology
  • Medical Imaging

Background:

  • Beta-thalassemia major is a genetic blood disorder requiring lifelong transfusion and chelation therapy.
  • Chronic medical management can potentially impact visual function.
  • Assessing visual parameters is crucial for comprehensive patient care.

Purpose of the Study:

  • To evaluate the contrast sensitivity function in patients with beta-thalassemia major undergoing regular treatment.
  • To compare visual function between beta-thalassemia patients and healthy controls.
  • To identify predictors of contrast sensitivity impairment in this cohort.

Main Methods:

  • Contrast sensitivity was measured at four spatial frequencies in 30 beta-thalassemia major patients and 30 controls.

Related Experiment Videos

  • Ophthalmic examinations, including fluorescein angiography, were performed.
  • Statistical analysis compared groups and correlated sensitivity with clinical variables (age, treatment duration, ferritin).

    • Main Results:

    • Beta-thalassemia patients exhibited significantly lower contrast sensitivity across all tested spatial frequencies compared to controls (p<0.0001).
    • Patient age was identified as the most significant predictor of reduced contrast sensitivity.
    • Duration of transfusion, chelation therapy, and serum ferritin levels were also analyzed for predictive value.

    Conclusions:

    • Contrast sensitivity testing is a sensitive method for detecting early visual changes in beta-thalassemia major.
    • This testing should be incorporated as a monitoring tool for patients receiving chronic transfusion and chelation therapy.
    • Monitoring visual function can aid in the early detection and management of potential complications.